Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rubicon OrganicsROMJF 50 Cash-to-Debt is 0.24 as of Mar. 2026, which is 70% below its 10-year median of 0.79. GuruFocus rates ROMJF with a GF Score™ of 50/100 and a GF Value™ of $0.38 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 985 Drug Manufacturers companies, Rubicon Organics ranks worse than 75.03% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Rubicon Organics's cash to debt ratio for the quarter that ended in Mar. 2026 was 0.24.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Rubicon Organicscouldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for Rubicon Organics's Cash-to-Debt or its related term are showing as below:
ROMJF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07 Med: 0.79 Max: 19.51
Current: 0.24
During the past 10 years, Rubicon Organics's highest Cash to Debt Ratio was 19.51. The lowest was 0.07. And the median was 0.79.
ROMJF's Cash-to-Debt is ranked worse than 75.03% of 985
companies
in the Drug Manufacturers industry
Industry Median: 1
vs ROMJF: 0.24
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Rubicon Organics Cash-to-Debt Related Terms
Rubicon Organics Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Rubicon Organics's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rubicon Organics Cash-to-Debt vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Rubicon Organics's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rubicon Organics (ROMJF) has a Cash-to-Debt of 0.24 as of Mar. 2026. This is 70% below median its historical median of 0.79. Over the past decade, Rubicon Organics' Cash-to-Debt has ranged from 0.07 to 19.51. According to the industry distribution chart, Rubicon Organics ranks #739 out of 985 companies in the Drug Manufacturers industry, placing it in the top 75%.
Is Rubicon Organics' Cash-to-Debt too high?
Rubicon Organics' current Cash-to-Debt of 0.24 is 70% below median its 10-year median of 0.79. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 19.51. The Drug Manufacturers industry median Cash-to-Debt is 1.00. Rubicon Organics' value of 0.24 is 76% below this industry median. Based on the distribution chart, Rubicon Organics ranks #739 out of 985 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Rubicon Organics has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rubicon Organics' Cash-to-Debt compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Rubicon Organics ranks #739 out of 985 companies for Cash-to-Debt. This places Rubicon Organics in the lower half of its industry. The industry median Cash-to-Debt is 1.00. Rubicon Organics' value of 0.24 is 76% below this benchmark. Historically, Rubicon Organics' own Cash-to-Debt has ranged from 0.07 to 19.51 over the past decade. While the company's 10-year median is 0.79 vs. the industry median of 1.00, Rubicon Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Drug Manufacturers company?
The median Cash-to-Debt among Drug Manufacturers companies is 1.00, based on 985 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rubicon Organics's current Cash-to-Debt of 0.24 is 76% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Cash-to-Debt is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rubicon Organics's current Cash-to-Debt is 0.24, which is 70% below median its own 10-year median of 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Organics stock overvalued right now?
Based on GuruFocus' analysis, Rubicon Organics (ROMJF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.38, compared to a current price of $0.32 — trading 17.1% below its estimated fair value. The current Cash-to-Debt is 0.24, which is 70% below median its 10-year median of 0.79 and 76% below the Drug Manufacturers industry median of 1.00. Rubicon Organics' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Rubicon Organics (ROMJF), the current Cash-to-Debt is 0.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rubicon Organics (ROMJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rubicon Organics stock appears to be undervalued.
The current stock price of $0.32 is trading 17.1% below its estimated GF Value™ of $0.38.
GuruFocus considers Rubicon Organics to be Modestly Undervalued.
Key valuation signals for ROMJF:
Cash-to-Debt: 0.24 (70% below median its 10-year median of 0.79)
GF Value™: $0.38 vs. price of $0.32 (17.1% below fair value)
Industry Position: 76% below the Drug Manufacturers median (#739 of 985)
No single metric tells the full story. See the ROMJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rubicon Organics Inc is engaged in the production and sale of cannabis in Canada. The company produces and processes organic cannabis at its wholly owned, federally licensed 125,000 square foot facility in Delta, British Columbia which it sells under its wholly owned brands and certain wholesale channels. Its brands include Simply Bare, 1964 Supply Co, Wildflower, and Homestead Cannabis Supply. It operates in a single reportable segment, being the production and sale of cannabis in Canada.
50GF Score
Get the complete analysis for ROMJF
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROMJF has been successfully added to your 
